Ifeyinwa Emmanuela OBİORAH, Metin ÖZDEMİRLİ, Alicia Henao VELASQUEZ

The Clinicopathologic Spectrum of IgG4-Related Disease

Immunoglobulin G4-related disease is a fibroinflammatory systemicdisease that is characterized by focal or diffuse organ infiltration byimmunoglobulin G4-bearing plasma cells. Immunoglobulin G4-relateddisease may affect any organ, and a high index of suspicion is necessaryfor early detection to avoid irreversible fibrosis, organ dysfunction,and death. Tumor-forming lesions are common radiological featuresof immunoglobulin G4-related disease that need to be differentiatedfrom malignancies. The diagnostic approach requires the integrationof clinical, biochemical, and radiographic manifestations withclassic histopathologic features, which remain crucial to diagnosis.The histology of immunoglobulin G4-related disease is determinedby a dense lymphoplasmacytic infiltrate, storiform fibrosis, andobliterative phlebitis in the presence of increased immunoglobulinG4-positve plasma cells. Although immunoglobulin G4-relateddisease forms a distinct, clinically independent disease category,many questions and problems remain unanswered, especially on itspathogenesis and the role of immunoglobulin G4. Advances in theunderstanding of immunoglobulin G4-related disease are likely tochange the diagnostic approach in the future and create potentialtargets for therapeutic purposes. Here we describe the concept ofimmunoglobulin G4-related disease and the most recent knowledge inthe clinico-pathological characteristics on this emerging disease. Thisstudy can guide clinicians in early diagnosis and prevent unnecessarysurgical resections.

PDF

___

Fujita A. Imaging of Sjögren Syndrome and Immunoglobulin G4-Related Disease of the Salivary Glands. Neuroimaging Clin N Am 2018;28:183-97.
Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 2015;74:1171-7.
Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010;62:1755-62.
Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013;62:1607-15.
Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A, Baldissera E, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol 2016;45:135-45.
Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arth Rheumatol 2015;67:1688-99.
Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 2015;74:190-5.
Culver EL, Sadler R, Simpson D, Cargill T, Makuch M, Bateman AC, et al. Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort. Am J Gastroenterol 2016;111:733-43.
Kawa S, Skold M, Ramsden DB, Parker A, Harding SJ. Serum IgG4 Concentration in IgG4-Related Disease. Clin Lab 2017;63:1323-37.
Bösmüller H, von Weyhern CH, Adam P, Alibegovic V, Mikuz G, Fend F. Paratesticular fibrous pseudotumor--an IgG4-related disorder? Virchows Arch 2011;458:109-13.
Cheuk W, Chan AC, Lam WL, Chow SM, Crowley P, Lloydd R, et al. IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases. Am J Surg Pathol 2009;33:1058-64.
Sato Y, Takeuchi M, Takata K, Ohno K, Iwaki N, Orita Y, et al. Clinicopathologic analysis of IgG4-related skin disease. Mod Pathol 2013;26:523-32.
Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P. IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 2011;96:1971-80.
Lu LX, Della-Torre E, Stone JH, Clark SW. Igg4-related hypertrophic pachymeningitis: Clinical features, diagnostic criteria, and treatment. JAMA Neurol 2014;71:785-93.
Brito-Zeron P, Ramos-Casals M, Bosch X, Stone JH. The clinical spectrum of IgG4- related disease. Autoimmun Rev 2014;13:1203-10.
Fujita T, Ando T, Sakakibara M, Hosoda W, Goto H. Refractory gastric ulcer with abundant IgG4-positive plasma cell infiltration: A case report. World J Gastroenterol 2010;16:2183-6.
Obiorah I, Hussain A, Palese C, Azumi N, Benjamin S, Ozdemirli M. IgG4-related disease involving the esophagus: a clinicopathological study. Dis Esophagus 2017;30:1-7.
Koizumi S, Kamisawa T, Kuruma S, Tabata T, Chiba K, Iwasaki S, et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4- related diseases? World J Gastroenterol 2013;19:5769-74.
Shigemitsu H, Koss MN. IgG4-related interstitial lung disease: a new and evolving concept. Curr Opin Pulm Med 2009;15:513-6.
Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, et al. IgG4- positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005;36:710-7.
Ryu JH, Yi ES. Immunoglobulin G4-Related Disease and the Lung. Clin Chest Med 2016;37:569-78.
Wick MR, O’Malley DP. Lymphadenopathy associated with IgG4-related disease: Diagnosis & differential diagnosis. Semin Diag Pathol 2018;35:61-6.
Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg
Tajima M, Nagai R, Hiroi Y. IgG4-related cardiovascular disorders. Int heart J. 2014;55:287-95.
Lian L, Wang C, Tian JL. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Int J Rheum Dis 2016;19:1049-55.
Pradhan D, Pattnaik N, Silowash R, Mohanty SK. IgG4-related kidney disease--A review. Pathol Res Pract 2015;211:707-11.
Khosroshahi A, Ayalon R, Beck LH Jr, Salant DJ, Bloch DB, Stone JH. IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor. Int J Rheumatol 2012;2012:139409.
Yoshita K, Kawano M, Mizushima I, Hara S, Ito Y, Imai N, et al. Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: distinction from non-IgG4- related tubulointerstitial nephritis. Nephrol Dial Transplant 2012;27:2755-61.
Kawano M, Saeki T. IgG4-related kidney disease--an update. Curr Opin Nephrol Hypertens 2015;24:193-201.
Deshpande V, Huck A, Ooi E, Stone JH, Faquin WC, Nielsen GP. Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol 2012;65:725-8.
Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) 2010;62:1312-8.
Riedel B. Die chronische, zur Bildung eisenharter Tumoren führende Entzündung der Schilddrüse. Verh Dtsch Ges Chir 1896;25:101-5.
Takagi D, Nakamaru Y, Fukuda S. Otologic Manifestations of Immunoglobulin G4- Related Disease. Ann Otol Rhinol Laryngol 2014;123:420-4.
Takano K, Abe A, Yajima R, Kakuki T, Jitsukawa S, Nomura K, et al. Clinical Evaluation of Sinonasal Lesions in Patients With Immunoglobulin G4-Related Disease. Ann Otol Rhinol Laryngol 2015;124:965-71.
Moteki H, Yasuo M, Hamano H, Uehara T, Usami S. IgG4-related chronic rhinosinusitis: a new clinical entity of nasal disease. Acta Otolaryngol 2011;131:518-26.
Pace C, Ward S. A rare case of IgG4-related sclerosing disease of the maxillary sinus associated with bone destruction. J Oral Maxillofac Surg 2010;68:2591-3.
Cain RB, Colby TV, Balan V, Patel NP, Lal D. Perplexing lesions of the sinonasal cavity and skull base: IgG4-related and similar inflammatory diseases. Otolaryngol Head Neck Surg 2014;151:496-502.
Prabhu SM, Yadav V, Irodi A, Mani S, Varghese AM. IgG4-related disease with sinonasal involvement: A case series. Indian J Radiol Imaging 2014;24:117-20.
Ishida M, Hotta M, Kushima R, Shibayama M, Shimizu T, Okabe H. Multiple IgG4- related sclerosing lesions in the maxillary sinus, parotid gland and nasal septum. Pathol Int 2009;59:670-5.
Goto H, Takahira M, Azumi A; Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol 2015;59:1-7.
Thompson A, Whyte A. Imaging of IgG4-related disease of the head and neck. Clin Radiol 2018;73:106-20.
Andrew N, Kearney D, Selva D. IgG4-related orbital disease: a meta-analysis and review. Acta Ophthalmol 2013;91:694-700.
Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: Single-center38. Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: Single-center experience and literature review. Semin Arthritis Rheum 2014;43:806-17.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 2012;22:1-14.
Takano K, Yamamoto M, Takahashi H, Himi T. Recent advances in knowledge regarding the head and neck manifestations of IgG4-related disease. Auris Nasus Larynx 2017;44:7-17.
Culver EL, Chapman RW. IgG4-related hepatobiliary disease: an overview. Nat rev Gastroenterol Hepatol 2016;13:601-12.
Kalaitzakis E, Levy M, Kamisawa T, Johnson GJ, Baron TH, Topazian MD, et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from PSC or cholangiocarcinoma. Clin Gastroenterol Hepatol 2011;9:800-3.
Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011;54:940-8.
Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006;101:2070-5.
Nakazawa T, Naitoh I, Hayashi K, Okumura F, Miyabe K, Yoshida M, et al. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol 2012;47:79-87.
Kamisawa T, Egawa N, Inokuma S, Tsuruta K, Okamoto A, Kamata N, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 2003;27:235-8.
Majumder S, Takahashi N, Chari ST. Autoimmune Pancreatitis. Dig Dis Sci 2017;62:1762-9.
Sugumar A, Chari ST. Autoimmune pancreatitis. J Gastroenterol Hepatol. 2011;26:1368-73.
Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czako L, et al. Longterm outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013;62:1771-6.
Sah RP, Chari ST, Pannala R, Sugumar A, Clain JE, Levy MJ, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterol 2010;139:140-8.
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Eng J Med 2001;344:732-8.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012;22:21-30.
Toyoda K, Oba H, Kutomi K, Furui S, Oohara A, Mori H, et al. MR imaging of IgG4-related disease in the head and neck and brain. AJNR Am J Neuroradiol 2012;33:2136-9.
Vasaitis L. IgG4-related disease: A relatively new concept for clinicians. Eur J Int Med 2016;27:1-9.
Zhang J, Chen H, Ma Y, Xiao Y, Niu N, Lin W, et al. Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imag 2014;41:1624-34.
Haldar D, Cockwell P, Richter AG, Roberts KJ, Hirschfield GM. An overview of the diagnosis and management of immunoglobulin G4-related disease. CMAJ 2016;188:953-61.
Martinez-Valle F, Fernandez-Codina A, Pinal-Fernandez I, Orozco-Galvez O, Vilardell-Tarres M. IgG4-related disease: Evidence from six recent cohorts. Autoimmun Rev 2017;16:168-72.
Chen H, Lin W, Wang Q, Wu Q, Wang L, Fei Y, et al. IgG4-related disease in a Chinese cohort: a prospective study. Scand J Rheumatol 2014;43:70-4.
Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 2014;69:269-72.
Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4- related disease: lessons for the rheumatologist. Nat Rev Rheumatol 2013;10:148-59.
Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998;160:3555-61.
Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538-46.
Kamisawa T, Anjiki H, Egawa N, Kubota N. Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol 2009;21:1136-9.
Mattoo H, Della-Torre E, Mahajan VS, Stone JH, Pillai S. Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy. Allergy 2014;69:399-402.
Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JG, Rak S, et al. Longterm clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010;125:131-8.
Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin exp allerg 2009;39:469-77.
Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod pathol 2012;25:1181-92.
Okazaki K, Umehara H. Current Concept of IgG4-Related Disease. Curr Top Microbiol Immunol 2017;401:1-17.
Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol 2011;23:114-8.
Stone JH, Zen Y, Deshpande V. IgG4-Related Disease. N Eng J Med 2012;366:539-51.
Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet 2015;385:1460-71.
Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4- Related Disease: clinical and laboratory features in 125 patients. Arthritis Rheumatol 2015;67:2466-75.
Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003;52:683-7.
Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis: Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, riedel’s thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med 1967;66:884-92.
Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas--an autonomous pancreatic disease? Am J Dig Dis 1961;6:688-98.